Related Experiment Videos
Salvage therapy for metastatic disease.
1Division of Medical Oncology, University of Colorado Health Sciences Center, Denver.
Seminars in Oncology
|August 1, 1990
Summary
Mitomycin plus vinblastine is an effective salvage therapy for metastatic breast cancer. This combination shows comparable efficacy to doxorubicin with a more favorable safety profile.
Area of Science:
- Oncology
- Medical treatment
Background:
- Salvage therapy for metastatic breast cancer is crucial when initial treatments fail.
- Doxorubicin-based regimens are a common but often toxic option.
Observation:
- A study evaluated 39 patients with metastatic breast cancer receiving mitomycin plus vinblastine as salvage therapy.
- Treatment response was observed within the first 4 weeks for responding patients.
Findings:
- Mitomycin plus vinblastine demonstrated comparable efficacy to doxorubicin salvage therapy.
- This combination exhibited a more favorable safety and toxicity profile compared to doxorubicin.
- Hematologic toxicities were manageable through dose adjustments or extended intervals.
Implications:
- Mitomycin plus vinblastine represents a viable and well-tolerated alternative for metastatic breast cancer salvage.
- This regimen offers a potentially less toxic option for patients with advanced breast disease.